Cargando…

Inframarginal externalities: COVID-19, vaccines, and universal mandates

COVID-19 vaccine mandates are in place or being debated across the world. Standard neoclassical economics argues that the marginal social benefit from vaccination exceeds the marginal private benefit; everyone vaccinated against a given infectious disease protects others by not transmitting the dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Albrecht, Brian C., Rajagopalan, Shruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589622/
https://www.ncbi.nlm.nih.gov/pubmed/36311039
http://dx.doi.org/10.1007/s11127-022-01006-z
_version_ 1784814344418099200
author Albrecht, Brian C.
Rajagopalan, Shruti
author_facet Albrecht, Brian C.
Rajagopalan, Shruti
author_sort Albrecht, Brian C.
collection PubMed
description COVID-19 vaccine mandates are in place or being debated across the world. Standard neoclassical economics argues that the marginal social benefit from vaccination exceeds the marginal private benefit; everyone vaccinated against a given infectious disease protects others by not transmitting the disease. Consequently, private levels of vaccination will be lower than the socially optimal levels due to free-riding, which requires mandates to overcome the problem. We argue that universal mandates based on free-riding are less compelling for COVID-19. We argue that because the virus can be transmitted even after receiving the vaccine, most of the benefits of the COVID-19 vaccine are internalized: vaccinated individuals are protected from the worst effects of the disease. Therefore, any positive externality may be inframarginal or policy irrelevant. Even when all the benefits are not internalized by the individual, the externalities mainly are local, mostly affecting family and closely associated individuals, requiring local institutional (private and civil society) arrangements to boost vaccine rates, even in a global pandemic. Economists and politicians must justify such universal vaccine mandates on some basis other than free-riding.
format Online
Article
Text
id pubmed-9589622
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-95896222022-10-24 Inframarginal externalities: COVID-19, vaccines, and universal mandates Albrecht, Brian C. Rajagopalan, Shruti Public Choice Article COVID-19 vaccine mandates are in place or being debated across the world. Standard neoclassical economics argues that the marginal social benefit from vaccination exceeds the marginal private benefit; everyone vaccinated against a given infectious disease protects others by not transmitting the disease. Consequently, private levels of vaccination will be lower than the socially optimal levels due to free-riding, which requires mandates to overcome the problem. We argue that universal mandates based on free-riding are less compelling for COVID-19. We argue that because the virus can be transmitted even after receiving the vaccine, most of the benefits of the COVID-19 vaccine are internalized: vaccinated individuals are protected from the worst effects of the disease. Therefore, any positive externality may be inframarginal or policy irrelevant. Even when all the benefits are not internalized by the individual, the externalities mainly are local, mostly affecting family and closely associated individuals, requiring local institutional (private and civil society) arrangements to boost vaccine rates, even in a global pandemic. Economists and politicians must justify such universal vaccine mandates on some basis other than free-riding. Springer US 2022-10-23 2023 /pmc/articles/PMC9589622/ /pubmed/36311039 http://dx.doi.org/10.1007/s11127-022-01006-z Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Albrecht, Brian C.
Rajagopalan, Shruti
Inframarginal externalities: COVID-19, vaccines, and universal mandates
title Inframarginal externalities: COVID-19, vaccines, and universal mandates
title_full Inframarginal externalities: COVID-19, vaccines, and universal mandates
title_fullStr Inframarginal externalities: COVID-19, vaccines, and universal mandates
title_full_unstemmed Inframarginal externalities: COVID-19, vaccines, and universal mandates
title_short Inframarginal externalities: COVID-19, vaccines, and universal mandates
title_sort inframarginal externalities: covid-19, vaccines, and universal mandates
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589622/
https://www.ncbi.nlm.nih.gov/pubmed/36311039
http://dx.doi.org/10.1007/s11127-022-01006-z
work_keys_str_mv AT albrechtbrianc inframarginalexternalitiescovid19vaccinesanduniversalmandates
AT rajagopalanshruti inframarginalexternalitiescovid19vaccinesanduniversalmandates